Geographic Disparities in Availability of Opioid Use Disorder Treatment for Medicaid Enrollees

被引:60
|
作者
Abraham, Amanda J. [1 ]
Andrews, Christina M. [2 ]
Yingling, Marissa E. [3 ]
Shannon, Jerry [4 ]
机构
[1] Univ Georgia, Sch Publ & Int Affairs, Dept Publ Adm & Policy, 202A Baldwin Hall 355 S Jackson St, Athens, GA 30602 USA
[2] Univ South Carolina, Hamilton Coll, Coll Social Work, Columbia, SC USA
[3] Clemson Univ, Coll Behav Social & Hlth Sci, Dept Sociol & Anthropol, Clemson, SC USA
[4] Univ Georgia, Dept Geog, Athens, GA 30602 USA
关键词
Medicaid; opioid use disorder; access; opioid treatment programs; ABUSE TREATMENT GAPS; PHYSICIAN PARTICIPATION; TREATMENT PROGRAMS; UNITED-STATES; COVERAGE; ACCESS; REFORM;
D O I
10.1111/1475-6773.12686
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
ObjectiveTo examine county-level geographic variation in treatment admissions among opioid treatment programs (OTPs) that accept Medicaid in the continental United States. Data Sources/Study SettingData come from the 2012 National Survey of Substance Abuse Treatment Services. Study Design/Data CollectionWe used local measures of spatial autocorrelation (LISA) analysis to identify (1) clusters of counties with higher and lower than average rates of opioid use disorders and (2) clusters of counties with higher and lower than average treatment admissions among OTPs that accept Medicaid, adjusting for county population size. Principal FindingsOur results reveal several clusters of counties with higher than average rates of opioid use disorder (OUD) and lower than average treatment admissions among OTPs that accept Medicaid. These clusters are highly concentrated in the Southeast region of the country and include Arkansas, Kentucky, Louisiana, Mississippi, and Tennessee. ConclusionsMedicaid enrollees in areas in the Southeast have the largest gaps between county-level OUD rates and estimated county-level capacity for treatment, as measured by county-level total treatment admissions among OTPs that accept Medicaid. Policy makers should consider strategies to increase the availability of OTPs with the capacity to serve Medicaid enrollees.
引用
收藏
页码:389 / 404
页数:16
相关论文
共 50 条
  • [41] Geographic variations in dental sealant utilization by Medicaid enrollees
    Okunseri, Christopher E.
    Okunseri, Elaye
    Garcia, Raul I.
    Visotcky, Alexis
    Szabo, Aniko
    JOURNAL OF PUBLIC HEALTH DENTISTRY, 2021, 81 (02) : 123 - 130
  • [42] ASSOCIATIONS BETWEEN STATE MEDICAID UTILIZATION MANAGEMENT POLICIES FOR BUPRENORPHINE, DRUG OVERDOSE BURDEN, AND OPIOID USE DISORDER TREATMENT AVAILABILITY
    Christine, Paul
    Lin, Allison
    Tipirneni, Renuka
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S39 - S40
  • [43] Are North Carolina clinicians delivering opioid use disorder treatment to Medicaid beneficiaries?
    Grove, Lexie R.
    Rao, Nikhil
    Domino, Marisa Elena
    ADDICTION, 2022, 117 (11) : 2855 - 2863
  • [44] Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder
    Christine, Paul J.
    Larochelle, Marc R.
    Lin, Lewei
    Mcbride, Jonathon
    Tipirneni, Renuka
    JAMA HEALTH FORUM, 2023, 4 (10): : E233549
  • [45] Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees
    Wen, Hefei
    Hockenberry, Jason M.
    JAMA INTERNAL MEDICINE, 2018, 178 (05) : 673 - 679
  • [46] Outpatient Prescription Opioid Use in Pediatric Medicaid Enrollees With Special Health Care Needs
    Feinstein, James A.
    Rodean, Jonathan
    Hall, Matt
    Doupnik, Stephanie K.
    Gay, James C.
    Markham, Jessica L.
    Bettenhausen, Jessica L.
    Simmons, Julia
    Garrity, Brigid
    Berry, Jay G.
    PEDIATRICS, 2019, 143 (06)
  • [47] Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications
    Grogan, Colleen M.
    Andrews, Christina
    Abraham, Amanda
    Humphreys, Keith
    Pollack, Harold A.
    Smith, Bikki Tran
    Friedmann, Peter D.
    HEALTH AFFAIRS, 2016, 35 (12) : 2289 - 2296
  • [48] Evaluation of a Medicaid Lock-in Program Increased Use of Opioid Use Disorder Treatment but No Impact on Opioid Overdose Risk
    Naumann, Rebecca B.
    Roberts, Andrew W.
    Marshall, Stephen W.
    Skinner, Asheley C.
    MEDICAL CARE, 2019, 57 (03) : 213 - 217
  • [49] Opioid analgesic and benzodiazepine prescribing among Medicaid-enrollees with opioid use disorders: The influence of provider communities
    Stein, Bradley D.
    Mendelsohn, Joshua
    Gordon, Adam J.
    Dick, Andrew W.
    Burns, Rachel M.
    Sorbero, Mark
    Shih, Regina A.
    Pacula, Rosalie Liccardo
    JOURNAL OF ADDICTIVE DISEASES, 2017, 36 (01) : 14 - 22
  • [50] PAIN MEDICATION (OPIOID AND NON-OPIOID) USE AMONG TEXAS MEDICAID ENROLLEES WITH SICKLE CELL DISEASE
    Kang, H. A.
    Barner, J. C.
    VALUE IN HEALTH, 2017, 20 (05) : A231 - A231